Bill

Bill > H1016


MA H1016

MA H1016
Establishing a commission to study maximum allowable costs lists


summary

Introduced
01/22/2019
In Committee
01/22/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

Relative to maximum allowable costs lists utilized by payers and pharmaceutical benefit managers to identify the maximum amount health plans will pay for certain prescription drugs. Financial Services.

AI Summary

This bill establishes a special commission to investigate the use of maximum allowable costs (MAC) lists, which are utilized by payers and pharmaceutical benefit managers (PBMs) to determine the maximum amount that a health plan will pay for various prescription drugs. The commission will review current practices surrounding the determination and use of MAC lists, industry-wide standardization for their development and use, and transparency in these processes. The commission will consist of 10 members, including representatives from the state government, healthcare industry, and advocacy groups. The commission is required to submit a report with its findings and any legislative recommendations to the relevant legislative committees within 180 days of the bill's passage.

Committee Categories

Business and Industry

Sponsors (12)

Last Action

Accompanied a study order, see H5160 (on 12/01/2020)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...